In preclinical analyses evaluating potential factors contributing to tumor growth in VHL-null Drosophila and human clear cell RCC, synthetic lethality was discovered between the decreased activity of cyclin-dependent kinases 4 and 6 (CDK4/6) and VHL inactivation [170]. The gene discussed is CDK4; the disease is neoplasm.